Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial

被引:0
|
作者
Zubin Punthakee
Michael E. Miller
Debra L. Simmons
Matthew C. Riddle
Faramarz Ismail-Beigi
David J. Brillon
Richard M. Bergenstal
Peter J. Savage
Irene Hramiak
Joseph F. Largay
Ajay Sood
Hertzel C. Gerstein
机构
[1] McMaster University,Department of Medicine
[2] Wake Forest University,Department of Biostatistical Sciences, Division of Public Health Sciences
[3] University of Utah,Division of Endocrinology, Department of Internal Medicine, School of Medicine
[4] VA Salt Lake City Health Care System,Division of Endocrinology, Diabetes & Clinical Nutrition
[5] Oregon Health & Science University,Department of Medicine
[6] Case Western Reserve University,Division of Endocrinology
[7] Cleveland VA Medical Center,National Institute of Diabetes and Digestive and Kidney Diseases
[8] Weill Cornell Medical College of Cornell University,Department of Medicine
[9] International Diabetes Center at Park Nicollet,Division of Endocrinology, Department of Medicine
[10] National Institutes of Health,undefined
[11] Western University,undefined
[12] University of North Carolina,undefined
[13] Louis Stokes VA Medical Center,undefined
来源
Diabetologia | 2014年 / 57卷
关键词
Intensive glucose lowering; Long-term glycaemic control; Post-intervention follow-up; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2030 / 2037
页数:7
相关论文
共 50 条
  • [21] The effects of intensive glycaemic control on body composition in patients with type 2 diabetes
    Bagg, W
    Plank, LD
    Gamble, G
    Drury, PL
    Sharpe, N
    Braatvedt, GD
    DIABETES OBESITY & METABOLISM, 2001, 3 (06): : 410 - 416
  • [22] The Role of Dietary Protein and Fat in Glycaemic Control in Type 1 Diabetes: Implications for Intensive Diabetes Management
    Paterson, Megan
    Bell, Kirstine J.
    O'Connell, Susan M.
    Smart, Carmel E.
    Shafat, Amir
    King, Bruce
    CURRENT DIABETES REPORTS, 2015, 15 (09)
  • [23] The Role of Dietary Protein and Fat in Glycaemic Control in Type 1 Diabetes: Implications for Intensive Diabetes Management
    Megan Paterson
    Kirstine J. Bell
    Susan M. O’Connell
    Carmel E. Smart
    Amir Shafat
    Bruce King
    Current Diabetes Reports, 2015, 15
  • [24] Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
    Hemmingsen, Bianca
    Lund, Soren S.
    Gluud, Christian
    Vaag, Allan
    Almdal, Thomas
    Hemmingsen, Christina
    Wetterslev, Jorn
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343 : 1136
  • [25] Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial
    Mette Y. Johansen
    Kristian Karstoft
    Christopher S. MacDonald
    Katrine B. Hansen
    Helga Ellingsgaard
    Bolette Hartmann
    Nicolai J. Wewer Albrechtsen
    Allan A. Vaag
    Jens J. Holst
    Bente K. Pedersen
    Mathias Ried-Larsen
    Diabetologia, 2020, 63 : 2410 - 2422
  • [26] Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial
    Johansen, Mette Y.
    Karstoft, Kristian
    MacDonald, Christopher S.
    Hansen, Katrine B.
    Ellingsgaard, Helga
    Hartmann, Bolette
    Albrechtsen, Nicolai J. Wewer
    Vaag, Allan A.
    Holst, Jens J.
    Pedersen, Bente K.
    Ried-Larsen, Mathias
    DIABETOLOGIA, 2020, 63 (11) : 2410 - 2422
  • [27] Intensive Glycemic Therapy in Type 2 Diabetes Patients With Cardiac Autonomic Dysfunction: The ACCORD Trial
    Huang, Yiquan
    Xie, Peihan
    Zhang, Shaozhao
    Liu, Menghui
    Huang, Rihua
    Xiong, Zhenyu
    Zhong, Xiangbin
    Lin, Yifen
    Zhou, Ziwei
    Zhang, Wenjing
    Guo, Yue
    Yang, Daya
    Zhuang, Xiaodong
    Liao, Xinxue
    MAYO CLINIC PROCEEDINGS, 2024, 99 (01) : 90 - 101
  • [28] Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD
    Hoogwerf, Byron J.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2008, 75 (10) : 729 - 737
  • [29] Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial
    O'Connor, P. J.
    Ismail-Beigi, F.
    Craven, T. E.
    Karl, D. M.
    Calles-Escandon, J.
    Hramiak, I.
    Genuth, S.
    Cushman, W. C.
    Gerstein, H. C.
    Probstfield, J. L.
    Katz, L.
    Schubart, U.
    DIABETOLOGIA, 2011, 54 : S23 - S24
  • [30] Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial -: mechanisms and implications
    DeVries, JH
    Snoek, FJ
    Kostense, PJ
    Heine, RJ
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (05) : 357 - 362